Literature DB >> 17062858

Clinical consequences of generic warfarin substitution: an ecological study.

J Michael Paterson, Muhammad Mamdani, David N Juurlink, Gary Naglie, Andreas Laupacis, Thérèse A Stukel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17062858     DOI： 10.1001/jama.296.16.1969-b

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence.

Authors:  Joshua J Gagne; Jennifer M Polinski; Wenlei Jiang; Sarah K Dutcher; Jing Xie; Joyce Lii; Lisa A Fulchino; Aaron S Kesselheim
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

2.  Did Generic Clopidogrel Commercialization Affect Trends of ER Consultations and Hospitalizations in the Population Treated with Clopidogrel?

Authors:  Jacinthe Leclerc; Claudia Blais; Louis Rochette; Denis Hamel; Line Guénette; Paul Poirier
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

3.  Differences in brand versus generic esmolol in the treatment of perioperative supraventricular tachycardia and hypertension: A pilot study.

Authors:  Diamanto Aretha; Panagiotis Kiekkas; Nektarios Sioulas; Fotini Fligou
Journal:  SAGE Open Med       Date:  2020-09-30

Review 4.  Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Alexander S Misono; Joy L Lee; Margaret R Stedman; M Alan Brookhart; Niteesh K Choudhry; William H Shrank
Journal:  JAMA       Date:  2008-12-03       Impact factor: 56.272

5.  Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance.

Authors:  Nancy El-Helou; Amal Al-Hajje; Rola Ajrouche; Sanaa Awada; Samar Rachidi; Salam Zein; Pascale Salameh
Journal:  Vasc Health Risk Manag       Date:  2013-03-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.